Objective: In this observational prospective study, we assessed the role of clinical variables and circulating biomarkers in graft occlusion at 18 months to identify a signature for graft occlusion.
Methods: A total of 330 patients undergoing primary elective coronary artery bypass grafting were enrolled. Blood collection for biomarker assessment was performed before surgery and discharge. Patients were then scheduled to undergo coronary computed tomography angiography at 18 months follow-up, and 179 patients underwent coronary computed tomography angiography 18 AE 2 months postoperatively.
Results: There were 46 of 503 (9.1%) occluded grafts; of these, 29 (63%) were venous and 17 (37%) were arterial grafts; overall, 43 of 179 patients (24%) had at least 1 occluded graft. Logistic mixed effects model assessing independent factors associated with graft occlusion identified that lower D-dimer levels at baseline (odds ratio [OR], 2.58; 95% confidence interval [CI], 1.36-4.89; P ¼ .00) and total protein content at discharge (OR, 1.09; 95% CI, 1.01-1.19; P ¼ .028) were related to overall graft occlusion at follow-up, along with an arterial graft other than the left internal thoracic artery (OR, 2.92; 95% CI, 1.24-6.9; P ¼ .078); moreover, a venous graft emerged was possibly associated with graft occlusion (OR, 1.51; 95% CI, 0.95-2.39; P ¼ .078). By separately analyzing saphenous vein and arterial grafts, D-dimer levels (OR, 2.67; 95% CI, 1.15-6.2; P ¼ .022 and OR, 2.5; 95% CI, 1.01-7.0; P ¼ .05 for venous and arterial graft, respectively) were still associated with arterial and venous graft occlusion at follow-up.
Conclusions:
We identified D-dimer as a biomarker associated with arterial and venous grafts occlusion. This may help stratify patients at risk of graft failure and identify new molecular targets to prevent this complication. (J Thorac Cardiovasc Surg 2018;155:200-7)
The estimated relationship between risk of graft occlusion at 1 year and preoperative D-dimer.
Central Message
We identified D-dimer as a biomarker associated with arterial and venous graft occlusion after CABG.
Perspective
The long-term success of CABG depends on graft patency. With this observational prospective study, we identified D-dimer as a biomarker associated with graft occlusion. This may help to stratify patients at risk of graft failure, identify new molecular targets to prevent this complication, and improve coronary artery disease therapy.
See Editorial Commentaries pages 208 and 210. Graft patency at follow-up represents a major concern after coronary artery bypass grafting (CABG) because it influences outcomes and can lead to increased rates of rehospitalization. Occluded venous grafts have been demonstrated in up to 40% of patients within 12 and 18 months, whereas occlusion of internal thoracic artery graft has been shown in 9% of patients. 1, 2 Several factors can be related to reduced graft patency, although there is not a complete comprehension on the causes and mechanisms that lead to graft occlusion. Off-pump CABG has resulted in a significantly lower patency of arterial and saphenous grafts in randomized and observational studies, [3] [4] [5] [6] and the debate on the more appropriate surgical strategy is still open. Except for potential technical issues, early vein graft failure almost exclusively is due to thrombotic occlusion, and the high incidence of early thrombotic graft failure with established antiplatelet regimens calls for a deeper knowledge of prothrombotic responses related to surgery and further improvement of preventive strategy.
CABG has been demonstrated to evoke a wide systemic inflammation response, evidenced by markedly elevated plasma levels of inflammatory mediators, which may regulate inflammatory and prothrombotic responses. Moreover, CABG may evoke activation and interaction of platelets, leukocytes, and vessel wall cells, which are all involved in the pathogenesis of graft failure. This protracted activation of hemostasis and inflammation, as well as increased oxidative stress and unfavorable endothelial milieu, persists for days and even weeks after surgery. [7] [8] [9] [10] [11] [12] Although some biomarkers have been demonstrated to be associated with the CABG inflammatory response and the relationship between prothrombotic/inflammatory responses and graft occlusion has been disclosed, few data on potential clinical and biological variables associated with graft thrombosis are available. This prospective study was carried out to identify which clinical data and biomarkers can be associated with coronary bypass graft occlusion at 1.5 years. 5, 9, 10, 12 
MATERIALS AND METHODS Study Design
The CoronAry bypass grafting: factors related to late events and Graft patEncy study is a prospective observational study that enrolled 330 white patients scheduled for elective CABG at a single university hospital. Inclusion criteria were age 18 to 89 years, elective primary CABG surgery, and signing a consent form. Exclusion criteria were concomitant surgery, major end-organ dysfunction, serious undercurrent illness or infection, known coagulation disorders, serum creatinine level greater than 2 mg/dL, and atrial fibrillation.
On enrollment, patients underwent clinical assessment and blood collection. Saphenous vein and radial and internal thoracic artery grafts were implanted according to the routine techniques of staff surgeons; in all cases, saphenous veins were harvested pedicled with a no-touch technique, whereas arterial grafts were harvested with their pedicle including satellite veins. Radial grafts were used only in case of greater than 90% target vessel stenosis (Table E1 shows the target anastomoses). Single or sequential distal anastomoses were performed at the surgeon's discretion. After surgery, all patients received aspirin 100 mg/day, whereas dual antiplatelet therapy was given to patients with a previous coronary stent implanted less than 12 months before surgery. Calcium channel blockers were used postoperatively in patients who received radial artery grafts, and statin therapy followed current guidelines.
All patients were then contacted to undergo computed tomography angiography (CCTA), which was performed 15 to 21 months after surgery. The primary end point was to identify clinical variables and circulating biomarkers associated with graft occlusion. Our Institutional Review Board and Ethical Committee approved the study, and all subjects gave written informed consent on enrollment. The trial was registered on ClinicalTrials.gov (Identifier: NCT00755248).
Sample Collection and Biochemical Assays
Blood collection was performed 1 to 3 days before surgery (baseline) and at patient discharge (discharge), usually between postoperative days 6 and 9, from a peripheral vein; plasma was prepared by centrifugation at 1500g for 20 minutes at 4 C within 30 minutes from venipuncture, divided into aliquots, and frozen at -80 C until assayed. Samples were frozen and thawed only once. Immunoenzymatic assays determination is described in the Supplemental Methods. 
Follow-up and Coronary Computed Tomography Scan
Patients who agreed to undergo coronary CCTA (Figure 1 ) underwent follow-up visit at the time of CCTA, including blood tests. CCTAs were performed with a 64-slice computed tomography scanner (VCT; GE Medical System, Milwaukee, Wis) with 64 3 0.625-mm collimation, 330-ms gantry rotation time. Dose modulation was attained with ''electrocardiographic gating'' for a maximum gantry delivery between 40% and 80% during the R-R interval. The ''smart prep'' scanning was performed to obtain a 4-chamber projection. A bolus of 80 mL of high-concentration contrast medium (Iomeron 400 mg/mL; Bracco, Milan, Italy) was administered intravenously at 5 mL/s, followed by 50 mL of saline injected at the same infusion rate. The scan was initiated according to the bolus-tracking technique. Graft occlusion was defined as the identification of a graft stump on computed tomography (body of graft without intraluminal contrast enhancement). 13, 14 Statistical Analysis The primary end point of the study was graft occlusion/patency at the 18-month computed tomography scan. It was treated as a dichotomous variable, and evaluation of potential risk factors was performed with logistic mixed-effect models that incorporated both fixed and random effects. Fixed effects are parameters associated with the entire population or with certain repeatable levels of experimental factors, whereas random effects are associated with individual experimental units. Individual patients were considered as random effect, and longitudinal data analysis permitted the evaluation of the hierarchic nested nature of the study and the betweenpatient variability. Different models were assessed for 3 different outcomes: (1) graft occlusion, (2) venous graft occlusion, and (3) arterial graft occlusion. Linear and nonlinear association of independent continuous variables and graft patency were explored with a flexible method using restricted cubic splines. The final models were validated by bootstrap (1000 runs) adjusted by the degree of optimism in bootstrap estimates.
Missing values occurred for ''previous smoke'' (9/330, 2.7%), ''New York Heart Association functional class'' (5/330, 1.5%), and ''Canadian Cardiovascular Society functional class'' (5/330, 1.5%). In the subgroup of patients who underwent graft patency assessment with coronary CCTA at follow-up, missing data occurred only for variable ''previous smoke'' (2/179, 1.1%). Missing values were substituted by single conditional mean imputation, as described to reduce bias and increase statistical power.
Two-sided statistics were performed with a significance level of .05. For all analyses, the R 3.0.3 software was used (R Development Core Team, 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0; http://www.R-project.org/). Longitudinal data analysis was performed with packages lme4 and nlme.
RESULTS
The baseline characteristics of the total study population at enrollment (n ¼ 330 patients) are listed in Table E2 .
Fifty-four percent of the study group (179 patients) underwent graft patency assessment with coronary CCTA at 18 AE 2 months after surgery; the clinical features of this patients cohort who underwent CCTA are reported in Table 1 . No in-hospital death occurred.
Coronary Computed Tomography Angiography
Follow-up CCTA at 18 months showed 46 of 503 (9.1%) occluded grafts, and 43 of 179 patients (24%) had at least 1 occluded graft. In detail, 40 patients had 1 occluded graft, and 3 patients had 2 occluded grafts. Of the 46 occluded grafts, 29 were saphenous vein grafts (63%), 11 were left internal thoracic arteries (30%), 5 were right internal thoracic arteries (11%), and 1 was a radial artery (2%). Of the 43 patients, 10 underwent coronary angiography, and in all these cases, there was agreement between CCTA and coronary angiography. Table 2 reports the details concerning grafts, anastomoses, and CCTA patency. In all occluded sequential grafts, the occlusion of all distal anastomoses was documented; however, the use of the sequential technique was not associated with higher occlusion rates.
Factors Associated With Graft Occlusion
At univariate analysis, several variables (Tables 1 and 3 ) were associated with the primary end point. The number of distal anastomoses and the type of graft were associated with graft occlusion, as well as variables indicating the complexity of the procedure (eg, skin-to-skin time), inotrope use, and red blood cell transfusions. Of note, preoperative Ddimer levels and total protein content at discharge were significantly associated with graft occlusion, whereas fibrinogen, haptoglobin, a1-antichymotrypsin, brain-derived natriuretic factor at baseline, and hematocrit level at discharge were possibly (.05>P<.2) associated with graft occlusion.
These variables were then analyzed by a logistic mixedeffects model assessing independent factors associated with graft occlusion (Table 4) . The model assessing risk factors for overall graft occlusion ( (Table 4 ) and arterial grafts (Table 4) , D-dimer levels (OR, 2.67; 95% CI, 1.15-6.2; P ¼ .022 and OR, 2.5; 95% CI, 1.01-7.0; P ¼ .05 for venous and arterial graft, respectively) were still associated with both arterial and venous graft occlusion at follow-up. Moreover, preoperative weight in Table 4 ). The Central Image shows the estimated relationship between the risk of graft occlusion at 18 months and the preoperative D-dimer for a patient weighing 60 kg who underwent CABG with 2 saphenous vein grafts without an additional arterial graft besides left internal thoracic artery, with a total protein content at discharge of 50 mg/mL.
DISCUSSION
CABG is still the procedure that provides angina relief, improved quality of life, and improved survival in patients with severe coronary artery disease. 15 The efficacy and outcomes of this procedure are in part limited by the occurrence of graft occlusion that can occur any time after this procedure.
2,16
This study shows that D-dimer is significantly associated with coronary graft occlusion, both arterial or venous, as assessed by CCTA.
Previous studies have searched for plasma variables predicting graft failure after an otherwise successful surgical myocardial revascularization in the very early (from 10 days to 3 months) period after coronary bypass surgery; from these studies, a variety of hemostatic variables, among which are Leiden mutation of factor V, 17 preoperative levels of thrombin-antithrombin complexes, 18 factor VIII, 19 tissue plasminogen activator, 19 plasminogen activator inhibitor activity, 20 early postoperative levels of fibrinogen, 19 thrombin-antithrombin complexes, 19 plasminogen activator inhibitor-1, 21 and reduced platelet sensitivity to aspirin on postoperative day 3, 22 have been proposed to play a role in early coronary bypass occlusion after surgery. These studies, however, in addition to assessing early patency, had 2 major constraints: the limited number of patients who were studied and the fact that only saphenous vein graft occlusions were investigated.
Even fewer studies investigated the relation between biomarkers and graft patency on medium-and long-term, showing that paraoxonase activity is lower, 3 whereas plasma asymmetric dimethylarginine activity is higher 23 in patients with failing saphenous vein graft at an average follow-up time of approximately 70 months; moreover, a recent study has suggested that fibrinogen levels are higher in patients with saphenous vein or radial artery occlusion at an average follow-up of 8 years. 24 All of these studies, unfortunately, did not assess biomarker levels before surgery and soon thereafter, thus limiting the possible use of these variables for perioperative risk stratification and preventive measures.
In this study, we show that D-dimer, a well-known marker of activated coagulation, that not only is routinely used in the diagnosis of venous thromboembolism but also is known to be associated with the risk of congestive heart disease, is independently associated with graft occlusions at short term after coronary bypass surgery. D-dimer levels are effectively related not only to overall graft occlusion but also to arterial and venous graft occlusions distinctly.
D-Dimer and Hemostatic Variables
D-dimer is a marker of fibrin formation and lysis, being a marker of both coagulation and fibrinolytic pathways. 4 Previous studies from our group showed that, after otherwise successful coronary bypass surgery, D-dimer levels are persistently elevated from baseline up to at least 2 months after surgery, 10 and this increase is similar in patients undergoing on-or off-pump surgical revascularization, probably as the consequence of increased fibrin turnover and of persistent inflammation. 5 In addition to the well-known diagnostic and prognostic value of D-dimer levels in venous thromboembolism, 6 2 recent meta-analyses have shown a definite role of this marker in arterial cardiovascular events. 25, 26 D-dimer levels have been shown to be associated with increased risk of stroke and arterial thrombosis in patients with peripheral arterial disease. 25, 27, 28 Of note, when low-dose warfarin was administered in the prevention of congestive heart disease, it was observed that the efficacy of warfarin was associated with the prolongation of international normalized ratio, which in turn was inversely related to the reduction of D-dimer levels in plasma. 29 In addition, D-dimer levels at baseline were reported to be higher in those patients undergoing primary percutaneous coronary intervention and developing restenosis. 30 In a previous study, we showed persistent activation of coagulation after CABG, in that thrombin antithrombin III and prothrombin fragment levels in plasma remained significantly higher, compared with baseline up to at least 1 month after surgery. 10 In this study, however, no association between thrombin antithrombin III or prothrombin fragment levels and subsequent events was found. This is consistent with previously published studies and may be related to their shorter (compared with that of D-dimer) half-lives in the circulation, thus limiting their power to detect transient coagulation activation. 31 Whether D-dimer association with arterial or venous graft occlusions reflects alterations in the fibrinolytic capacity or an increased thrombotic state is still to be determined and requires further studies. However, in view of the role of D-dimer as a predictor of both vein and arterial graft occlusions, we hypothesize that patients with increased preoperative D-dimer levels would benefit from therapies aimed at reducing thrombin generation in the perioperative period.
Same Predictors for Arterial and Venous Graft Thrombosis?
Among the several clinical and biological markers, identified data were consistent in all of the 3 models tested for arterial or saphenous vein graft occlusion and both. In all models, low weight was associated with graft occlusions, probably reflecting smaller coronary targets. Even more relevant is the observation that D-dimer is an independent risk factor for both arterial and venous graft occlusion, thus providing the proof of concept that the biological mechanisms underlying short-term graft failure of arterial and venous grafts are more similar than dissimilar. In this context, strategies aimed at inhibiting thrombin generation or effects may reduce the risk of irrespectively of graft type.
Study Limitations
This study was performed on patients presenting with normal or moderately impaired renal function and with sinus rhythm before surgery to reduce the possible dropouts for CCTA, and for this reason the generalization of the findings of the present study to the whole population of patients undergoing coronary bypass grafting is limited. In addition, noninvasive CCTA was used in this study for graft evaluation instead of invasive coronary angiography, which is currently considered the gold standard imaging technique for coronary circulation. However, a large body of data have demonstrated a diagnostic accuracy of 99% to 100% of CCTA versus invasive angiography in the detection of significant stenosis or occlusion of bypass grafts, 32 and the American Heart Association/American College of Cardiology guidelines for the use of cardiac computed tomography consider the evaluation with CCTA of graft patency after CABG definitively appropriate.
Another limit of the study is that of the enrolled patients, only 54% underwent CCTA evaluation of graft patency after CABG. This is because many patients undergoing surgery at Centro Cardiologico (Monzino, Milan) live far from the hospital and did not return to the hospital for the follow-up.
In this study, 18-month patency of the right internal thoracic artery and the radial artery has been lower than expected from previous literature. In our series, both these grafts were seldom used (19 right internal thoracic arteries and 5 radial arteries). In Centro Cardiologico, the routine practice is ''1 left internal thoracic artery plus vein,'' and we reserve the second or third arterial graft for selected patients. This also may imply lower confidence of the surgeon when performing arterial revascularization. For this reason, data concerning right internal thoracic artery and radial artery patency need to be taken with great caution because they may due to the limited number of grafts studied or to a lower confidence in arterial grafting, because our routine practice in CABG usually foresees the use of the left internal thoracic artery internal plus greater saphenous vein.
CONCLUSIONS
This study has identified preoperatively assessed D-dimer levels as a biomarker associated with the risk of increased coronary bypass graft occlusion at short-term follow-up. D-dimer is associated with both arterial and venous graft occlusion and may help preoperatively to identify patients at higher risk for this complication. These findings may pave the way for the use of antithrombotic or anti-inflammatory approaches, thus offering improved patient-centered care.
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LITA, Left internal thoracic artery; RITA, right internal thoracic artery; SVG, saphenous vein graft. *In 1 case, there was the total occlusion of a sequential graft directed to 2 obtuse marginal branches. Units of red blood cells transfused (n) CT, Computed tomography; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; EF, ejection fraction; euroSCORE, European System for Cardiac Operative Risk Evaluation; LMT, left main trunk; LAD, left anterior descending; LCX, left circumflex artery; RCA, right coronary artery; LITA, left internal thoracic artery; FG, free graft; RITA, right internal thoracic artery; CPB, cardiopulmonary bypass.
